Overview The Congenital Cataract Gene Panel is a genetic test that identifies mutations in genes associated with congenital and early-onset cataracts. It helps determine the underlying genetic cause of lens opacity present at birth or developing during infancy and childhood, enabling accurate diagnosis, prognosis, and family counseling.
Who Should Get Tested?
Infants born with cataracts
Children with bilateral or unexplained cataracts
Individuals with a family history of congenital cataracts
Patients with cataracts associated with developmental delay or genetic syndromes
Couples seeking genetic counseling due to inherited eye disorders
What Does the Test Detect?
The panel analyzes multiple genes linked to congenital cataracts, including:
CRYAA, CRYAB, CRYBA1, CRYBB2
GJA3, GJA8
HSF4
MIP
PAX6
BFSP2
And several other clinically relevant genes
Symptoms That May Indicate Testing
Cloudy or white appearance of the eye lens
Poor vision from birth
Nystagmus (rapid eye movements)
Strabismus (crossed eyes)
Delayed visual development
Family history of inherited cataracts
Benefits of the Test
Confirms the genetic cause of congenital cataracts
Supports early diagnosis and treatment planning
Helps predict inheritance patterns and recurrence risk
Guides genetic counseling for affected families
Assists in screening at-risk family members
May identify syndromic conditions associated with cataracts
Sample Required
Peripheral Blood: 3–5 mL (EDTA)
Method
Next-Generation Sequencing (NGS)
Confirmation of selected variants by Sanger Sequencing (when applicable)
Turnaround Time
Approximately 3–6 weeks (may vary depending on laboratory workflow)
Why Choose Advanced BioCare Laboratories?
Comprehensive analysis of clinically significant cataract-related genes
High-quality NGS technology with expert interpretation
Accurate and reliable genetic reporting
Supports ophthalmologists, pediatricians, and genetic counselors in patient management